Diagnosis and treatment of ECL cell tumors

Yale Journal of Biology and Medicine

Volumn 71, Issue 3-4, 1999, Pages 311-323

  Cadiot, Guillaume ^a   Cattan, Daniel ^b   Mignon, Michel ^a  

^a BICHAT HOSPITAL   (France)

^b Centre Hospitalier Intercommunal de Villeneuve Saint Georges   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ATROPHIC GASTRITIS; CONFERENCE PAPER; ENDOSCOPIC SURGERY; ENTEROCHROMAFFIN CELL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE ENDOCRINE NEOPLASIA; PROGNOSIS; STOMACH TUMOR; ZOLLINGER ELLISON SYNDROME;

CARCINOID TUMOR; ENDOSCOPY; ENTEROCHROMAFFIN-LIKE CELLS; GASTRITIS, ATROPHIC; HUMANS; OMEPRAZOLE; STOMACH NEOPLASMS; ZOLLINGER-ELLISON SYNDROME;

EID: 0032819006     PISSN: 00440086     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (63)

1. Lehy, T., Cadiot, G., Mignon, M., Ruszniewski, P., and Bonfils, S. Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome. Gut 33:1275-1279, 1992.
2. Solcia, E., Capella, C., Fiocca, R., Rindi, G., and Rosai, J. Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type 1 multiple endocrine neoplasia. A newly recognized association. Am. J. Surg. Pathol. 14:503-513, 1990.
3. Bordi, C., Cocconi, G., Togni, R., Vezzadini, P., and Missale, G. Gastric endocrine cell proliferation, association with Zollinger-Ellison syndrome. Arch. Pathol. 98:274-278, 1974.
4. Rindi, G., Bordi, C., Rappel, S., La Rosa, S., Stolte, M., and Solcia, E. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J. Surg. 20:168-172, 1996.
5. Cattan, D., Roucayrol, A.M., Launay, J.M., Callebert, J., and Courillon-Mallet, A. Serum gastrin and argyrophil cell hyperplasia relationships in fundic atrophic gastritis. In: The stomach as an endocrine organ. Hakanson, R. and Sundler, F., eds. Amsterdam: Elsevier Science Publishers; 1991, pp. 425-48.
6. Borch, K., Renvall, H., and Liedberg, G. Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anemia. Gastroenterology 88:638-648, 1985.
7. Solcia, E., Bordi, C., Creutzfeldt, W., Dayal, Y., Dayan, A.D., Falkmer, S., Grimelius, L., and Havu, N. Histopathological classification of nonantral gastric endocrine growths in man. Digestion 41:185-200, 1988.
8. Ahlman, H., Kölby, L., Lundell, L., Olbe, L., Wängberg, B., Granérus, G., Grimelius, L., and Nilsson, O. Clinical management of gastric carcinoid tumors. Digestion 55(suppl 3):77-85, 1994.
9. Modlin, I.M. and Tang, L.H. The gastric enterochromaffin-like cell: an enigmatic cellular link. Gastroenterology 111:783-810, 1996.
10. Carney, J.A., Go, V.L.W., Fairbanks, V.F., Moore, S.B., Alport, E.C., and Nora, F.E. The syndrome of gastric argyrophil carcinoid tumors and nonantral gastric atrophy. Ann. Intern. Med. 99:761-766, 1983.
11. Bordi, C., Yu, J.Y., Baggi, M.T., Davoli, C., Pilato, F.P., Baruzzi, G., Gardini, G., Zamboni, G., Franzin, G., Papotti, M., and Bussolati, G. Gastric carcinoids and their precursor lesions: histologic and immunohistochemical study of 23 cases. Cancer 67:663-72, 1991.
12. Sjöblom, S.M., Sipponen, P., Karonen, S.L., and Jarvinen, H.J. Mucosal argyrophil endocrine cells in pernicious anaemia and upper gastrointestinal carcinoid tumours. J. Clin. Pathol. 42:371-377, 1989.
13. Stockbrügger, R.W., Menon, G.G., Beilby, J.O.W., Mason, R.R., and Cotton, P.B. Gastroscopic screening in 80 patients with pernicious anaemia. Gut 24:1141-1147, 1983.
14. Gough, D.B., Thompson, G.B., Crotty, T.B., Donohue, J.H., Kvols, L.K., Carney, J.A., Grant, C.S. and Nagorney, D.M. Diverse clinical and pathological features of gastric carcinoid and the relevance of hypergastrinemia. World J. Surg. 18:473-480, 1994.
15. Rappel, S., Altendorf-Hofmann, A. and Stolte, M. Prognosis of gastric carcinoid tumours. Digestion 56:455-62, 1995.
16. Modlin, I.M., Gilligan, C.J., Lawton, G.P., Tang, L.H., West, A.B., and Darr, U. Gastric carcinoids: the Yale experience. Arch. Surg. 130:250-256, 1995.
17. Wilander, E., El-Salhy, M., and Pitkänen, P. Histopathology of gastric carcinoids: a survey of 42 cases. Histopathology 8:183-193, 1984.
18. Thomas, R.M., Baybick, J.H., Elsayed, A.M., and Sobin, L.H. Gastric carcinoids: an immunohistochemical and clinicopathologic study of 104 patients. Cancer 73:2053-2058, 1994.
19. Rindi, G., Luinetti, O., Cornaggia, M., Capella, C., and Solcia, E. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology 104:994-1006, 1993.
20. Krishnamurthy, S., Termanini, B., Jensen, R.T., and Dayal, Y. Gastric endocrine cell status in familial and sporadic Zollinger-Ellison syndrome. Gastroenterology 110:A162, 1996.
21. Cadiot, G., Vissuzaine, C., Potet, F., and Mignon, M. Fundic argyrophil carcinoid tumor in a patient with sporadic-type Zollinger-Ellison syndrome. Dig. Dis. Sci. 40:1275-1278, 1995.
22. Feurle, G.E. Argyrophil cell hyperplasia and a carcinoid tumour in the stomach of a patient with sporadic Zollinger-Ellison syndrome. Gut 35:275-277, 1994.
23. Jensen, R.T. Gastrinoma as a model for prolonged hypergastrinemia in the human. In: Walsh, J.M., ed. Gastrin. New York: Raven Press; 1993, pp. 373-393.
24. Cadiot, G., Lehy, T., Ruszniewski, P., Bonfils, S., and Mignon, M. Gastric endocrine cell evolution in patients with Zollinger-Ellison syndrome. Influence of gastrinoma growth and long-term omeprazole therapy. Dig. Dis. Sci. 38:1307-1317, 1993.
25. Cadiot, G., Laurent-Puig, P., Thuille, B., Lehy, T., Mignon, M., and Olschwang, S. Is the multiple endocrine neoplasia type 1 gene a suppressor for fundic argyrophil tumors in Zollinger-Ellison syndrome? Gastroenterology 105:579-582, 1993.
26. Solcia, E., Fiocca, R., Sessa, F., Rindi, G., Gianatti, A., Cornaggia, M., and Capella, C. Morphology and natural history of gastric endocrine tumors. In: Hakanson, R., and Sundler, F., eds. The stomach as an endocrine organ. Amsterdam: Elsevier Science; 1991, pp. 473-498.
27. Lehy, T., Mignon, M., Cadiot, G., Elouaer-Blanc, L., Ruszniewski, Ph., Lewin, M.J.M., and Bonfils, S. Gastric endocrine cell behavior in Zollinger-Ellison patients upon long-term potent antisecretory treatment. Gastroenterology 96:1029-1040, 1989.
28. Mignon, M., Lehy, T., Bonnefond, A., Ruszniewski, Ph., Labeille, D., and Bonfils, S. Development of gastric argyrophil carcinoid tumors in a case of Zollinger-Ellison syndrome with primary hyperparathyroidism during long-term antisecretory treatment. Cancer 59:1959-62, 1987.
29. Syversen, U., Mignon, M., Bonfils, S., Kristensen, A, and Waldum, H.L. Chromogranin A and pancreastatin-like immunoreactivity in serum of gastrinoma patients. Acta Oncologica 32:161-165, 1993.
30. Ruszniewski, P., Lehy, T., Cheret, A.M., Laigneau, J.P., Cadiot, G., Mignon, M., and Lewin, M.J.M. Histamine release by ECL-omas in short-term culture. Gastroenterology 102:A754, 1992.
31. Bordi, C., D'Adda, T., Ceda, G.P., Bertele, A., Pilato, F.P., Ceresini, G., Baggi, M.T., and Missale, G. Glycoprotein hormone alpha subunit in endocrine cells of human oxyntic mucosa. Studies on its relation with neuroendocrine tumours. Hepatogastroenterology 37:108-114, 1990.
32. Bardram, L., Agner, T., and Hagen, C. Levels of subunits of gonadotropins can be increased in Zollinger-Ellison syndrome, both in patients with malignant tumours and with apparently benign disease. Acta Endocrinol. (Copenh) 118:135-41, 1988.
33. Sjöblom, S.M., Sipponen, P., Karonen, S.L., and Jarvinen, H.J. Argyrophil cell hyperplasia and carcinoid tumours in oxyntic mucosa of the stomach. Dependence on duration of pernicious anaemia. Eur. J. Gastroenterol. Hepatol. 3:153-157, 1991.
34. Borch, K., Renvall, H., Liedberg, G., and Andersen, B.N. Relations between circulating gastrin and endocrine cell proliferation in the atrophic gastric fundic mucosa. Scand. J. Gastroenterol. 21:357-63, 1986.
35. McCloy, R.F., Arnold, R., Bardhan, K.D., Cattan, D., Klinkenberg-Knol, E., Maton, P.N., Riddell, R.H., Sipponen, P., and Walan, A. Pathophysiological effects of long-term acid suppression in man. Dig. Dis. Sci. 40(suppl):96S-120S, 1995.
36. Cattan, D., Roucayrol, A.M., Launay, J.M., Callebert, J., Charasz, N., Nurit, Y., Belaïche, J., and Kalifat R. Circulating gastrin, endocrine cells, histamine content, and histidine decarboxylase activity in atrophic gastritis. Gastroenterology 97:586-596, 1989.
37. Borch, K. Epidemiologic, clinicopathologic, and economic aspects of gastroscopic screening of patients with pernicious anemia. Scand. J. Gastroenterol. 21:21-30, 1986.
38. Sjöblom, S.M., Sipponen, P., Miettinen, M., Karonen, S.L., and Järvinen, H.J. Gastroscopic screening for gastric carcinoids and carcinoma in pernicious anemia. Endoscopy 20:52-56, 1988.
39. Sjöblom, S.M., Sipponen, P., and Järvinen, H. Gastroscopic follow up of pernicious anaemia patients. Gut 34:28-32, 1993.
40. Armbrecht, U., Stockbrügger, R.W., Rode, J., Menon, G.G., and Cotton, P.B. Development of gastric dysplasia in pernicious anaemia: a clinical and endoscopie follow up study of 80 patients. Gut 31:1105-9, 1990.
41. Roucayrol, A.M. and Cattan, D. Evolution of fundic argyrophil cell hyperplasia in nonantral atrophic gastritis. Gastroenterology 99:1307-14, 1990.
42. Weber, H.C., Venzon, D.J., Lin, J.-T., Fishbein, V.A., Orbuch, M., Strader, D.B. et al. Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. Gastroenterology 108:1637-49, 1995.
43. Cadiot, G., Vuagnat, A., Doukhan, I., Murat, A., Bonnaud, G., Delemer, B., Thiéfin, G., Veyrac, M., Ruszniewski, P., Proye, C., and Mignon, M. GENEM 1, and GRESZE. Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1: a french multicentric study in 71 patients. Gastroenterology 1999. In Press.
44. Walker, F.M., Lehy, T., Bernuau, G., Sobhani, I., Bayle, D., Feldman, G., and Lewin, M.J.M. Detection of gastrin mRNA in human antral mucosa and digestive endocrine tumors by in situ hybridization: a correlative study with immunocytochemistry and electron microscopy. J Histochem. Cytochem. 40:1363-1372, 1992.
45. Yoshikane, H., Tsukamoto, Y., Niwa, Y., Goto, H., Hase, S., Mizutani, K., and Nakamura, T. Carcinoid tumors of the gastrointestinal tract: evaluation with endoscopic ultrasonography. Gastrointest. Endosc. 39:375-383, 1993.
46. Ruszniewski, P., Podevin, P., Cadiot, G., Marmuse, J.P., Mignon, M., Vissuzaine, C., Bonfils, S., and Lehy, T. Clinical, anatomical, and evolutive features of patients with the Zollinger-Ellison syndrome combined with type 1 multiple endocrine neoplasia. Pancreas 8:295-304, 1993.
47. MacFarlane, M.P., Fraker, D.L., Alexander, H.R., Norton, J.A., Lubensky, I., and Jensen, R.T. Prospective study of surgical resection of duodenal and pancreatic gastrinomas in multiple endocrine neoplasia type 1. Surgery 118:973-80, 1995.
48. Cadiot, G., Lehy, T., and Bonfils, S. Action of somatostatin analogue (SMS 201-995) on the growth-promoting effect resulting from sustained achlorhydria in rat gastric mucosa, with special reference to endocrine cell behaviour. Eur. J. Clin. Invest. 18:360-368, 1988.
49. Ruszniewski, P., Ramdani, A., Cadiot, G., Lehy, T., Mignon, M., and Bonfils, S. Long-term treatment with octreotide in patients with the Zollinger-Ellison syndrome. Eur. J. Clin. Invest. 23:296-301, 1993.
50. Ferraro, G., Annibale, B., Marignani, M., Azzoni, C., D'Adda, T., D'Ambra, G., Bordi, C., and Delle Fave, G. Effectiveness of octreotide in controlling fasting hypergastrinemia and related enterochromaffin-like cell growth. J. Clin. Endocrinol. Metab. 81:677-683, 1996.
51. Modlin, I.M., Kumar, R., Nangia, A., Soroka, C.J., Pasikhov, D., and Goldenring, J.R. Gastrindependent inhibitory effects of octreotide on the genesis of gastric ECL-omas. Surgery 112:1048-1058, 1992.
52. Tsutsui, S., Shinomura, Y., Kanayama, S., Yabu, M., Miyazaki, Y., Kawabata, S., Kondo, S., Murayama, Y., Imamura, I., and Matsuzawa, Y. Inhibition of gastrin-stimulated enterochromaffin-like cell proliferation and mucosal histamine production in the rat stomach by the somatostatin analogue octreotide. Regul. Pept. 57:175-182, 1995.
53. Tielemans, Y., Andersson, K., Mattsson, H., Schally, A.V., and Willems, G. Abnormal ECL cell proliferation induced by omeprazole is abolished by the somatostatin analogue RC-160. Gastroenterology 102:A581, 1992.
54. D'Adda, T., Annibale, B., Delle Fave, G., and Bordi, C. Oxyntic endocrine cells of hypergastrinaemic patients. Differential response to antrectomy or octreotide. Gut 38:668-674, 1996.
55. Reubi, J.C., Waser, B., Horisberger, U., Halter, F., Soroka, C.J., Kumar, R.R., Goldenring, J.R., and Modlin, I.M. Identification of somatostatin and gastrin receptors on the enterochromaffin-like cells from Mastomys gastric tumors. Endocrinology 131:166-172, 1992.
56. Prinz, C., Sachs, G., Walsh, H.J., Coy, H.D., and Wu, V.S. The somatostatin receptor subtype on rat enterochromaffinlike cells. Gastroenterology 107:1067-1074, 1994.
57. Fiasse, R., Deprez, P., Rahier, J., Descamps, Ch., Jonard, Ph., Gérard, J., Druez, P., Gigot J.F., and Pauwels, S. Long term octreotide treatment of gastric carcinoid tumors in two patients with Zollinger-Ellison syndrome (ZES) associated with multiple endocrine neoplasia type 1 (MEN 1). Gastroenterology 108:A966, 1995.
58. Cattan D, Roucayrol AM. Nonantral gastric endocrine growhs in nonantral atrophic gastritis with achlorhydria. II) Carcinoid tumors. Gastroenterol. Clin. Biol. 15 (5bis), 36C-40C, 1991.
59. Eckhauser, F.E., Lloyd, R.V., Thompson, N.W., Raper, S.E., and Vinik, A.I. Antrectomy for multicentric, argyrophil gastric carcinoids: a preliminary report. Surgery 104:1046-1053, 1989.
60. Hirschowitz, B.I., Griffith, J., Pellegrin, D., and Cummings, O.W. Rapid regression of enterochromaffinlike cell gastric carcinoids in pernicious anemia after antrectomy. Gastroenterology 102:1409-1418, 1992.
61. Cattan, D., Belaiche, J., Bernades, P., Bonneville, B., Bories, C., Darriulat, L., Grandguillaume, J., Grimaud, J.C., Lafon, J., Marche, C., Misset, J.L., Paolaggi, J.A., Ponsot, P., Rey, J.F., Treffot, M.J., and Weissmann. Tumeurs carcinoïdes fundiques sur gastrite atrophique. Quel traitement? Gastroenterol. Clin. Biol. 13bis:A38, 1989.
62. Harvey, R.F. Spontaneous resolution of multifocal gastric enterochromaffin-like cell carcinoid tumours. Lancet i:821, 1988.
63. Gilligan, C.J., Lawton, G.P., Tang, L.H., West, A.B., and Modlin, I.M. Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion. Am. J. Gastroenterol. 90:338-352, 1995.